Trade Azenta Inc - AZTA CFD

Azenta, Inc. Company profile

About Azenta Inc

Azenta, Inc. (Azenta), formerly Brooks Automation, Inc., is a provider of life sciences solutions worldwide, enabling therapies to market faster. Azenta provides a full suite of cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The Company's services include genomics services, sample and management solutions, sample and material storage, clinical trial management, drug products and cell therapies, sample prep and lab services, lab moving and biological transport, information technology solutions, and business continuity and risk mitigation. Azenta has operations in North America, Europe and Asia.

Financial summary

BRIEF: For the three months ended 31 December 2021, Azenta Inc revenues increased 18% to $139.7M. Net income before extraordinary items increased 6% to $2.9M. Revenues reflect Life sciences Services segment increase of 24% to $89.8M, Life science products segment increase of 10% to $49.9M, North America segment increase of 22% to $90.1M, Europe segment increase of 11% to $28.6M, Asia/Pacific segment increase of 12% to $21M.

Equity composition

Common $.01 Par, 12/11, 125M auth., 79,716,314 issd., less 13,461,869 shs. in Treas. @ $201M. Insiders own 3.35%. IPO: 2/95, 2M @ $8 by PaineWebber. PO: 3/00, 3,250,000 shs.(2.75M by Co.) @ $76 by CS First Boston. 5/02, Company acq.